99 related articles for article (PubMed ID: 31922703)
1. Cancer genetics-one family at a time.
Foulkes W
Clin Invest Med; 2019 Dec; 42(4):E7-E13. PubMed ID: 31922703
[TBL] [Abstract][Full Text] [Related]
2. Germline genetic variants in men with prostate cancer and one or more additional cancers.
Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
[TBL] [Abstract][Full Text] [Related]
3. Germline pathogenic variants in BRCA1, BRCA2, PALB2 and RAD51C in breast cancer women from Argentina.
Cerretini R; Mercado G; Morganstein J; Schiaffi J; Reynoso M; Montoya D; Valdéz R; Narod SA; Akbari MR
Breast Cancer Res Treat; 2019 Dec; 178(3):629-636. PubMed ID: 31446535
[TBL] [Abstract][Full Text] [Related]
4. Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumour.
Palculict TB; Ruteshouser EC; Fan Y; Wang W; Strong L; Huff V
J Med Genet; 2016 Jun; 53(6):385-8. PubMed ID: 26566882
[TBL] [Abstract][Full Text] [Related]
5. Analysis of DICER1 in familial and sporadic cases of transposition of the great arteries.
Sabbaghian N; Digilio MC; Blue GM; Revil T; Winlaw DS; Foulkes WD
Congenit Heart Dis; 2018 May; 13(3):401-406. PubMed ID: 29399970
[TBL] [Abstract][Full Text] [Related]
6. BRG1 and SMARCAL1 transcriptionally co-regulate DROSHA, DGCR8 and DICER in response to doxorubicin-induced DNA damage.
Patne K; Rakesh R; Arya V; Chanana UB; Sethy R; Swer PB; Muthuswami R
Biochim Biophys Acta Gene Regul Mech; 2017 Sep; 1860(9):936-951. PubMed ID: 28716689
[TBL] [Abstract][Full Text] [Related]
7. Ten years of DICER1 mutations: Provenance, distribution, and associated phenotypes.
de Kock L; Wu MK; Foulkes WD
Hum Mutat; 2019 Nov; 40(11):1939-1953. PubMed ID: 31342592
[TBL] [Abstract][Full Text] [Related]
8. DICER1 syndrome can mimic different genetic tumor predispositions.
Mehraein Y; Schmid I; Eggert M; Kohlhase J; Steinlein OK
Cancer Lett; 2016 Jan; 370(2):275-8. PubMed ID: 26577641
[TBL] [Abstract][Full Text] [Related]
9. Identification of two 14q32 deletions involving DICER1 associated with the development of DICER1-related tumors.
Herriges JC; Brown S; Longhurst M; Ozmore J; Moeschler JB; Janze A; Meck J; South ST; Andersen EF
Eur J Med Genet; 2019 Jan; 62(1):9-14. PubMed ID: 29698806
[TBL] [Abstract][Full Text] [Related]
10. Whole genome sequencing reveals DICER1 as a candidate predisposing gene in familial Hodgkin lymphoma.
Bandapalli OR; Paramasivam N; Giangiobbe S; Kumar A; Benisch W; Engert A; Witzens-Harig M; Schlesner M; Hemminki K; Försti A
Int J Cancer; 2018 Oct; 143(8):2076-2078. PubMed ID: 29708584
[No Abstract] [Full Text] [Related]
11. Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patients.
Schroeder C; Faust U; Krauße L; Liebmann A; Abele M; Demidov G; Schütz L; Kelemen O; Pohle A; Gauß S; Sturm M; Roggia C; Streiter M; Buchert R; Armenau-Ebinger S; Nann D; Beschorner R; Handgretinger R; Ebinger M; Lang P; Holzer U; Skokowa J; Ossowski S; Haack TB; Mau-Holzmann UA; Dufke A; Riess O; Brecht IB
Eur J Hum Genet; 2023 Oct; 31(10):1139-1146. PubMed ID: 37507557
[TBL] [Abstract][Full Text] [Related]
12. Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer.
Kim H; Cho DY; Choi DH; Oh M; Shin I; Park W; Huh SJ; Nam SJ; Lee JE; Kim SW
Breast Cancer Res Treat; 2017 Jan; 161(1):95-102. PubMed ID: 27783279
[TBL] [Abstract][Full Text] [Related]
13.
Schultz KAP; Williams GM; Kamihara J; Stewart DR; Harris AK; Bauer AJ; Turner J; Shah R; Schneider K; Schneider KW; Carr AG; Harney LA; Baldinger S; Frazier AL; Orbach D; Schneider DT; Malkin D; Dehner LP; Messinger YH; Hill DA
Clin Cancer Res; 2018 May; 24(10):2251-2261. PubMed ID: 29343557
[TBL] [Abstract][Full Text] [Related]
14. Pediatric imaging in DICER1 syndrome.
Bueno MT; Martínez-Ríos C; la Puente Gregorio A; Ahyad RA; Villani A; Druker H; van Engelen K; Gallinger B; Aronoff L; Grant R; Malkin D; Greer MC
Pediatr Radiol; 2017 Sep; 47(10):1292-1301. PubMed ID: 28474256
[TBL] [Abstract][Full Text] [Related]
15. DICER1 exons 25 and 26 mutations are rare in common human tumours besides Sertoli-Leydig cell tumour.
Kim MS; Lee SH; Yoo NJ; Lee SH
Histopathology; 2013 Sep; 63(3):436-8. PubMed ID: 23763383
[No Abstract] [Full Text] [Related]
16. [DICER1: A new model of epigenetic tumor suppressor gene].
Diana JS; Orbach D
Bull Cancer; 2015 Oct; 102(10):802-3. PubMed ID: 26387821
[No Abstract] [Full Text] [Related]
17. Familial multinodular goiter and Sertoli-Leydig cell tumors associated with a large intragenic in-frame
Apellaniz-Ruiz M; de Kock L; Sabbaghian N; Guaraldi F; Ghizzoni L; Beccuti G; Foulkes WD
Eur J Endocrinol; 2018 Feb; 178(2):K11-K19. PubMed ID: 29187512
[TBL] [Abstract][Full Text] [Related]
18. Dicer1 Phosphomimetic Promotes Tumor Progression and Dissemination.
Aryal NK; Pant V; Wasylishen AR; Rimel BJ; Baseler L; El-Naggar AK; Mutch DG; Goodfellow PJ; Arur S; Lozano G
Cancer Res; 2019 May; 79(10):2662-2668. PubMed ID: 30914430
[No Abstract] [Full Text] [Related]
19. Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort Study.
Khan NE; Bauer AJ; Schultz KAP; Doros L; Decastro RM; Ling A; Lodish MB; Harney LA; Kase RG; Carr AG; Rossi CT; Field A; Harris AK; Williams GM; Dehner LP; Messinger YH; Hill DA; Stewart DR
J Clin Endocrinol Metab; 2017 May; 102(5):1614-1622. PubMed ID: 28323992
[TBL] [Abstract][Full Text] [Related]
20. Structural renal abnormalities in the DICER1 syndrome: a family-based cohort study.
Khan NE; Ling A; Raske ME; Harney LA; Carr AG; Field A; Harris AK; Williams GM; Dehner LP; Messinger YH; Hill DA; Schultz KAP; Stewart DR
Pediatr Nephrol; 2018 Dec; 33(12):2281-2288. PubMed ID: 30178239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
